Effectiveness of intravitreal ranibizumab combined with a oral supplement rich in docosahexaenoic acid (DHA) plus antioxidants in patients with diabetic macular edema, a randomised, single blind contolled study.
Phase of Trial: Phase II
Latest Information Update: 23 Jan 2018
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 23 Jan 2018 New trial record